Showing 1 - 2 results of 2 for search 'Xiao-Hui Zhao', query time: 0.01s Refine Results
  1. 1
    Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab

    Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab by Chang-Fu Liu, Xiao-Hui Zhao, Shi-Bo Zhu, Hai-Peng Yu, Wen-Ge Xing, Hui-Kai Li

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Research in context

    Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Res... by Wei Gao, Zhao-Long Pan, Xiao-Hui Zhao, Lu Yang, Jun-Bo Cao, Dong-Yang Li, Hai-Jing Zheng, Chen Liu, Guang-Tao Li, Xu Bao, Xiao-Meng Liu, Wei-Hao Zhang, Xiao-Lin Zhu, Bo-Han Xiao, Tian-Qiang Song, Qiang Li, Wei Lu, Wen-Ge Xing, Wei Zhang

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: